22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › 89bio, Inc. › 2024-2025

89bio, Inc. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and 89bio, Inc.’s Form 8-K, filed May 30, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 198Asset managers, any item
  • 976Fund votes
  • May 28, 2025Meeting date

Results at a glance

Meeting of May 28, 2025: 5 items on 89bio, Inc.’s Form 8-K, filed May 30, 2025: 3 elected · 2 passed (calculated).

Dissent

Significant dissent: 1 director (49.0% against).

Notable dissent: 1 director (15.9% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025

Explore 89bio, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by 89bio, Inc.

These tallies are 89bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 30, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

89bio, Inc. — official shareholder meeting results, meeting held May 28, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Martin Babler 104,787,288---- 19,874,8269,430,895 84%Elected—
Elect Director: Derek DiRocco, Ph.D. 63,538,191---- 61,123,9239,430,895 51.0%Elected—
Elect Director: Lota Zoth, C.P.A. 121,166,878---- 3,495,2369,430,895 97%Elected—
2. Ratification of KPMG LLP as Independent Auditor 134,065,959---- 25,6351,415 99.9%Passed (calculated)—
3. Advisory Vote on Executive Compensation 114,892,0459,734,42035,649 --9,430,895 92%Passed (calculated)—

Source: 89bio, Inc., Form 8-K, filed with the SEC on May 30, 2025 — read the filing on EDGAR.

How asset managers voted at the 89bio, Inc. 2024-2025 meeting

198 asset managers disclosed a vote on at least one 89bio, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Derek DiRocco, Ph.D.

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

51.0% Majority: yes · of votes cast

FOR 51.0%WITHHELD
FOR: 63,538,191WITHHELD: 61,123,923
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D.

89bio, Inc.’s own tally for this item (“Elect Director: Derek DiRocco, Ph.D.”): 63,538,191 for, 61,123,923 withheld, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 51.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D.” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,001,3640 00For
JANUS INVESTMENT FUND00 06,488,879Withhold
BlackRock00 4,718,4820Abstain
Fidelity3,160,2060 047,095For
HARBOR FUNDS00 1,970,3230Abstain
State Street4,1840 01,758,549Withhold
Charles Schwab1,006,3020 00For
TIAA905,2540 00For
FINANCIAL INVESTORS TRUST00 512,4710Abstain
Principal00 0355,665Withhold
Equitable00 0333,760Withhold
Harbor Funds II314,7720 00For
Royce226,0000 00For
RBB FUND, INC.00 0214,837Withhold
Dimensional00 0204,286Withhold
American Century00 0184,648Withhold
Goldman Sachs00 0182,930Withhold
Lord Abbett00 0166,323Withhold
Morgan Stanley00 0114,764Withhold
Northern Trust00 088,434Withhold
Lincoln Financial00 081,800Withhold
Direxion Shares ETF Trust00 073,308Withhold
Global X00 066,466Withhold
ProShares00 059,723Withhold
Pacific Life00 055,229Withhold

Fund voting reports, all 59 managers: 12,742,895 for, 10,825,394 withheld, 7,353,260 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D.” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH00 0883,000Withhold

Institutional-manager reports, all 1 managers: 883,000 withheld.

Elect Director: Lota Zoth, C.P.A.

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 121,166,878WITHHELD: 3,495,236
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A.

89bio, Inc.’s own tally for this item (“Elect Director: Lota Zoth, C.P.A.”): 121,166,878 for, 3,495,236 withheld, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A.” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,001,3640 00For
JANUS INVESTMENT FUND6,488,8790 00For
BlackRock4,718,4820 00For
Fidelity3,207,3010 00For
HARBOR FUNDS1,970,3230 00For
State Street1,762,7330 00For
Charles Schwab1,006,3020 00For
TIAA905,2540 00For
FINANCIAL INVESTORS TRUST00 512,4710Abstain
Principal00 0355,665Withhold
Equitable326,8200 06,940For
Harbor Funds II314,7720 00For
Royce226,0000 00For
RBB FUND, INC.00 0214,837Withhold
Dimensional00 0204,286Withhold
American Century184,6480 00For
Goldman Sachs182,9300 00For
Lord Abbett166,3230 00For
Morgan Stanley114,7640 00For
Northern Trust88,4340 00For
Lincoln Financial81,8000 00For
Direxion Shares ETF Trust73,3080 00For
Global X66,4660 00For
ProShares59,7230 00For
Pacific Life55,2290 00For

Fund voting reports, all 59 managers: 29,615,769 for, 787,217 withheld, 518,563 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Election of Directors: To be elected for terms expiring in 2028: Lota Zoth, C.P.A.” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH883,0000 00For

Institutional-manager reports, all 1 managers: 883,000 for.

Elect Director: Martin Babler

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD
FOR: 104,787,288WITHHELD: 19,874,826
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Directors: To be elected for terms expiring in 2028: Martin Babler

89bio, Inc.’s own tally for this item (“Elect Director: Martin Babler”): 104,787,288 for, 19,874,826 withheld, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “Election of Directors: To be elected for terms expiring in 2028: Martin Babler” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,001,3640 00For
JANUS INVESTMENT FUND6,488,8790 00For
BlackRock00 4,718,4820Abstain
Fidelity3,160,2060 047,095For
HARBOR FUNDS1,970,3230 00For
State Street1,762,6660 067For
Charles Schwab00 01,006,302Withhold
TIAA905,2540 00For
FINANCIAL INVESTORS TRUST00 512,4710Abstain
Principal00 0355,665Withhold
Equitable136,6210 0197,139Mixed
Harbor Funds II314,7720 00For
Royce226,0000 00For
RBB FUND, INC.00 0214,837Withhold
Dimensional00 0204,286Withhold
American Century184,6480 00For
Goldman Sachs182,9300 00For
Lord Abbett166,3230 00For
Morgan Stanley114,7640 00For
Northern Trust88,4340 00For
Lincoln Financial81,8000 00For
Direxion Shares ETF Trust73,3080 00For
Global X00 066,466Withhold
ProShares59,7230 00For
Pacific Life00 055,229Withhold

Fund voting reports, all 59 managers: 23,338,486 for, 2,252,450 withheld, 5,330,613 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Election of Directors: To be elected for terms expiring in 2028: Martin Babler” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH883,0000 00For

Institutional-manager reports, all 1 managers: 883,000 for.

Advisory Vote on Executive Compensation

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 7 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 114,892,045AGAINST: 9,734,420

Prior year: 98.6% for (May 29, 2024 meeting) ▼ 6.4 pts

Details: description as filed, official tally, votes by 198 asset managers

Description as filed by funds: Approval of, on an advisory basis, the compensation of the Company's named executive officers.

89bio, Inc.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 114,892,045 for, 9,734,420 against, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,001,3640 00For
JANUS INVESTMENT FUND6,488,8790 00For
BlackRock4,718,4820 00For
Fidelity3,207,3010 00For
HARBOR FUNDS1,970,3230 00For
State Street1,762,300433 00For
Charles Schwab1,006,3020 00For
TIAA905,2540 00For
FINANCIAL INVESTORS TRUST512,4710 00For
Principal355,6650 00For
Equitable333,7600 00For
Harbor Funds II314,7720 00For
Royce226,0000 00For
RBB FUND, INC.214,8370 00For
Dimensional0204,286 00Against
American Century0184,648 00Against
Goldman Sachs182,9300 00For
Lord Abbett166,3230 00For
Morgan Stanley114,7640 00For
Northern Trust88,4340 00For
Lincoln Financial81,8000 00For
Direxion Shares ETF Trust73,3080 00For
Global X066,466 00Against
ProShares59,7230 00For
Pacific Life55,2290 00For

Fund voting reports, all 59 managers: 30,356,313 for, 565,236 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 155 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Janus Henderson19,856,1890 00For
SUVRETTA CAPITAL MANAGEMENT, LLC14,436,3760 00For
RA CAPITAL MANAGEMENT, L.P.12,342,6920 00For
Deep Track Capital, LP9,345,5780 00For
Avoro Capital Advisors LLC4,348,9890 00For
BlackRock4,119,2025,389 00For
PICTET ASSET MANAGEMENT SA3,900,3140 00For
State Street3,796,346531 00For
WESTFIELD CAPITAL MANAGEMENT CO LP3,265,85142,530 00For
GEODE CAPITAL MANAGEMENT, LLC2,829,2080 00For
Logos Global Management LP02,750,000 00Against
RTW INVESTMENTS, LP1,967,5270 00For
Redmile Group, LLC01,804,211 00Against
Citadel1,637,0640 00For
SILVERARC CAPITAL MANAGEMENT, LLC1,177,6000 00For
EMERALD MUTUAL FUND ADVISERS TRUST1,082,9730 00For
Charles Schwab1,006,3030 00For
Northern Trust939,5840 00For
Nuveen912,4470 00For
Erste Asset Management GmbH883,0000 00For
Rock Springs Capital Management LP841,4340 00For
EMERALD ADVISERS, LLC823,9750 00For
Candriam S.C.A.0822,548 00Against
ADAR1 Capital Management, LLC798,1380 00For
Woodline Partners LP700,7540 00For

Institutional-manager reports, all 155 managers: 97,904,143 for, 7,766,987 against, 5,360 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of KPMG LLP as Independent Auditor

Calculated outcomeFund totals may overlapAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 134,065,959WITHHELD: 25,635
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.

89bio, Inc.’s own tally for this item (“2. Ratification of KPMG LLP as Independent Auditor”): 134,065,959 for, 25,635 withheld, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 59 asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard7,001,3640 00For
JANUS INVESTMENT FUND6,488,8790 00For
BlackRock4,718,4820 00For
Fidelity3,207,3010 00For
HARBOR FUNDS1,970,3230 00For
State Street1,762,7330 00For
Charles Schwab1,006,3020 00For
TIAA905,2540 00For
FINANCIAL INVESTORS TRUST512,4710 00For
Principal355,6650 00For
Equitable333,7600 00For
Harbor Funds II314,7720 00For
Royce226,0000 00For
RBB FUND, INC.214,8370 00For
Dimensional204,2860 00For
American Century184,6480 00For
Goldman Sachs182,9300 00For
Lord Abbett166,3230 00For
Morgan Stanley114,7640 00For
Northern Trust88,4340 00For
Lincoln Financial81,8000 00For
Direxion Shares ETF Trust73,3080 00For
Global X66,4660 00For
ProShares59,7230 00For
Pacific Life55,2290 00For

Fund voting reports, all 59 managers: 30,921,549 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ” at 89bio, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH883,0000 00For

Institutional-manager reports, all 1 managers: 883,000 for.

Largest 89bio, Inc. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 145,984,182 shares outstanding at the time of that meeting.

Fund voting reports: top 89bio, Inc. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 4.80%
2JANUS INVESTMENT FUND 4.44%
3BlackRock 3.23%
4Fidelity 2.20%
5HARBOR FUNDS 1.35%
6State Street 1.21%
7Charles Schwab 0.69%
8TIAA 0.62%
9FINANCIAL INVESTORS TRUST 0.35%
10Principal 0.24%
Institutional-manager reports: top 89bio, Inc. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Janus Henderson 13.60%
2SUVRETTA CAPITAL MANAGEMENT, LLC 9.89%
3RA CAPITAL MANAGEMENT, L.P. 8.45%
4Deep Track Capital, LP 6.40%
5Avoro Capital Advisors LLC 2.98%
6BlackRock 2.83%
7PICTET ASSET MANAGEMENT SA 2.67%
8State Street 2.60%
9WESTFIELD CAPITAL MANAGEMENT CO LP 2.27%
10GEODE CAPITAL MANAGEMENT, LLC 1.94%

Reported 89bio, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

89bio, Inc. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Entities affiliated with Janus Henderson Group plc20,256,065 13.88%Proxy statement (DEF 14A), proxy filed April 15, 2025
Entities affiliated with RA Capital20,013,733 13.71%Proxy statement (DEF 14A), proxy filed April 15, 2025
Entities affiliated with Suvretta Capital Management, LLC10,202,696 6.99%Proxy statement (DEF 14A), proxy filed April 15, 2025
BlackRock10,075,344 6.90%Form 13F, quarter ended March 31, 2025
Entities affiliated with RTW Investments, LP7,378,548 5.05%Proxy statement (DEF 14A), proxy filed April 15, 2025
Vanguard Group7,163,609 4.91%Form 13F, quarter ended March 31, 2025
JANUS HENDERSON GROUP PLC5,378,185 3.68%Schedule 13G, filed October 7, 2025
Citadel Advisors5,180,736 3.55%Form 13F, quarter ended March 31, 2025
BVF PARTNERS L P/IL4,333,885 2.97%Schedule 13G, filed February 14, 2025
State Street4,030,307 2.76%Form 13F, quarter ended March 31, 2025

Percentages above are of 145,984,182 shares outstanding, as reported by 89bio, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At 89bio, Inc.'s shareholder meeting held May 28, 2025, in the 2024-2025 proxy season, 198 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 976 separate fund positions. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers. — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: 89bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 30, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from 89bio, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

89bio, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page).

Cite this page

Proxy Votes Now, “89bio, Inc. 2025 Annual Meeting: Shareholder Vote Results & Fund Votes”, https://proxyvotesnow.com/company/89bio-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.